Why Report Negative Controls?
An observational comparison can remain biased after measured covariates have been adjusted for or balanced. A negative control is a variable chosen because a particular causal effect should be absent, while some of the same sources of bias or data problems may still be present. Its purpose is diagnostic: an unexpected association can raise concern about the design or analysis, while an estimate near zero may be reassuring only to a limited degree.
A negative control is not simply an outcome or exposure that happens to produce a nonsignificant result. Its role needs a substantive justification, including why the causal effect should be absent and why the control is informative about the target comparison. A check that fails those conditions may be difficult to interpret, whatever its p-value.
State the Rationale and Assumptions
For a negative-control outcome, the central causal condition is that changing treatment would not change the control outcome: \(Y^{NC}(1)=Y^{NC}(0)\). For a negative-control exposure, the corresponding condition is that changing the control exposure would not change the target outcome. These conditions describe the absence of the particular causal effect being tested. They do not imply that the control is unrelated to treatment, outcome, or covariates in observed data.
A useful control also needs a reason to be informative. For example, it may share causes with treatment or the target outcome, be subject to similar measurement or selection processes, or be measured in a way that could expose a temporal or coding problem. A control that has no plausible connection to the sources of bias in the target analysis may have little diagnostic value. Conversely, if treatment can truly affect the proposed negative-control outcome, an observed association does not isolate bias.
These conditions are substantive and cannot usually be established by a statistical test. Before presenting an estimate, explain the causal argument for no effect and the expected connection to relevant bias. State possible threats to that argument, such as indirect effects, shared downstream causes, or different measurement quality. A pre-treatment outcome, for example, cannot be caused by a later treatment, but it may have a different relationship to confounding than the target outcome.
What to Report
For each control, report its scientific rationale, operational definition, timing, and analysis. Give enough detail for readers to understand who could have the control value, how it was recorded, and whether it was measured before or after treatment assignment. Explain how the control was handled in the analysis: for example, whether the primary matching or weighting procedure was reused, whether the same covariates and sample were used, and what effect measure was estimated.
Then report the estimate, its units or scale, and uncertainty. For a ratio measure, report the ratio and a confidence interval; for a difference, identify the groups and the units of the difference. Include the number of observations or events where relevant. If the control analysis differs from the target analysis, state why. A reader should not have to guess whether an apparent contrast reflects a different sample, model, outcome definition, or adjustment strategy.
A useful interpretation separates three statements: what the estimate says about the control association, what that association may signal about the design, and what it does not establish about the target effect. A non-null control estimate may be consistent with residual confounding, but it may also reflect a flawed control assumption, measurement error, selection, or chance. A near-null estimate is not proof that all important biases are absent.
Worked Example: Reporting a Negative-Control Outcome
Suppose a hypothetical matched cohort compares a medication with a comparator for a target outcome of hospitalization within six months. Investigators choose a recorded diagnosis that occurred before treatment initiation as a negative-control outcome. They justify the choice by saying a later medication cannot cause a diagnosis already recorded before treatment, while the diagnosis may share health-care-use and illness-related causes with treatment selection and the target hospitalization.
The investigators define the control as a diagnosis recorded during the 90 days before the index date, use the matched sample and the same covariate-adjusted analysis plan, and estimate an adjusted odds ratio of 1.03. The standard error of the log odds ratio is 0.045. The estimate is not derived from the crude event counts alone; it is the stated result of the adjusted model.
The log estimate is \(\log(1.03)=0.0296\). A 95% confidence interval on the log scale is:
Exponentiating the endpoints gives \([\exp(-0.0586),\exp(0.1178)]=[0.943,\ 1.125]\), or approximately 0.94 to 1.13. The Wald statistic is \(z=0.0296/0.045=0.66\), corresponding to a two-sided p-value of about 0.51. The estimated odds of the pre-index diagnosis are about 3% higher in the medication group, but the interval includes 1 and is compatible with both lower and higher odds.
The result does not show a clear association for this control outcome. It does not demonstrate that the target comparison is free of residual confounding: this control may be insensitive to biases affecting hospitalization, and its confidence interval leaves room for nontrivial associations. The temporal rationale and the shared-cause rationale should be reported separately, since the first supports no treatment effect and the second supports diagnostic relevance.
How a Falsification Result Can Signal Bias
The basic diagnostic logic can be expressed by separating the true causal effect, bias, and sampling variation. For a valid negative-control outcome, the true causal effect of treatment on that outcome is zero. In a simplified additive representation, the estimated control association is therefore:
where \(B_{NC}\) represents bias affecting the control comparison and \(\varepsilon_{NC}\) is sampling error. Under the no-effect condition, a sufficiently precise nonzero estimate is evidence that something besides the hypothesized causal effect is operating, such as confounding, selection, measurement error, or a violated analysis assumption. It does not identify which explanation is responsible.
This representation also shows why a near-zero result is limited evidence. The observed estimate can be near zero because \(B_{NC}\) is small, because the control does not share the relevant bias, or because sampling error offsets a nonzero bias. Nor does the equation imply that \(B_{NC}\) equals bias in the target estimate. That would require additional assumptions about how bias transfers between the control and target outcomes. Negative controls generally do not quantify target bias without such assumptions.
Worked Example: A Future Exposure as a Falsification Check
In a hypothetical study, the target exposure is a treatment initiated at baseline and the target outcome is a later clinical event. Investigators define a control exposure as initiation of a different service during the following six months, then examine an outcome recorded before that future initiation. They reason that a future service cannot cause an earlier event. However, they also acknowledge that worsening health may influence both the earlier event and later service initiation.
In the specified adjusted model, the estimated risk ratio comparing people who later did versus did not initiate the service is 1.38, with a 95% confidence interval from 1.04 to 1.83. On the log scale, \(\log(1.38)=0.322\). The interval endpoints on that scale are \(\log(1.04)=0.0392\) and \(\log(1.83)=0.6043\). The implied standard error is approximately \((0.6043-0.0392)/(2\times1.96)=0.144\); the Wald statistic is \(0.322/0.144=2.24\), giving a two-sided p-value of about 0.025.
The estimated risk of the earlier event is 38% higher among those who later initiate the service, and the interval excludes 1. This is an unexpected association under the stated no-causal-effect rationale. It may flag confounding by health status, selection, or a timing or measurement problem. It does not show that the future service caused the earlier event, and it does not establish that the target treatment estimate is biased upward by 38%. The control's association is a warning to interpret alongside its rationale and limitations, not a correction factor for the target result.
When a Null Result Is Not Reassuring
A nonsignificant test does not establish that a negative-control association is absent. Its uncertainty may be broad enough to include associations that would matter scientifically. Reporting only “no association was found” or only a p-value hides this issue. Present the estimate and interval, and explain which magnitudes remain compatible with the data.
Worked Example: Interpreting an Imprecise Control Estimate
A hypothetical matched analysis estimates a negative-control risk difference of 0.3 percentage points, treated group minus comparator group, with a standard error of 0.765 percentage points. The estimate is \(0.3\) percentage points, or \(0.003\) on the risk scale. Its 95% confidence interval in percentage points is:
The test statistic is \(z=0.3/0.765=0.39\), with a two-sided p-value of about 0.69. The data do not provide strong evidence of a difference for this control outcome. But the interval is compatible with a decrease of 1.20 percentage points or an increase of 1.80 percentage points, so the result is not precise evidence that the difference is negligible. A claim of negligible association would need a prespecified threshold for practical importance and an analysis showing adequate precision relative to that threshold.
Diagnostics, Alternatives, and Common Pitfalls
Before interpreting a falsification check, examine whether its design matches its stated purpose. Check that the control is defined independently of the observed result, its timing supports the no-effect rationale, and the target analysis sample and adjustment choices are described. Consider whether the control is measured with enough accuracy and frequency to detect an association. Sparse events, a small sample, or a control weakly related to the relevant confounders can make a null result uninformative. A positive result also needs investigation: it can reflect a failed no-effect assumption rather than residual bias alone.
Negative controls complement, rather than replace, other approaches. The earlier material on sensitivity analyses for unmeasured confounding addresses how conclusions might change under specified bias scenarios. Negative controls instead examine associations that should be absent under a stated causal rationale. Neither approach automatically removes bias. A negative control can be especially useful as a transparent design check, while a quantitative sensitivity analysis can make assumptions about the size or structure of bias explicit.
Common mistake: “The negative-control test was not significant, so unmeasured confounding is ruled out.” This reasoning treats failure to reject a null as proof of no association and assumes the control is sensitive to every relevant bias. The correction is to report the effect estimate and interval, discuss the control's power and validity, and say only that the observed data did or did not reveal a clear association for that particular control.
Check Your Understanding
Answer each question, then compare with the solutions below.
- What two distinct rationales should be given for a negative-control outcome?
- A negative-control exposure has an estimated risk ratio of 1.00 with a 95% confidence interval from 0.70 to 1.42. Can the result rule out residual confounding? Why or why not?
- Why does a non-null association for a valid negative-control exposure not establish that the exposure caused the outcome?
- What should a report include besides a p-value for a negative-control analysis?
Solutions. (1) Explain why treatment cannot causally affect the control outcome and why the control may share causes or bias mechanisms relevant to the target comparison. (2) No. The interval is broad and includes appreciable associations in both directions; moreover, even a precise null for this control would not rule out biases that it does not capture. (3) The no-effect rationale says the causal effect should be absent. A non-null association may instead reflect confounding, selection, measurement problems, chance, or a mistaken no-effect assumption. (4) Report the control's rationale, timing and operational definition, analysis sample and method, effect measure and units, estimate, confidence interval, and a contextual explanation of what the finding does and does not indicate.